ClinicalTrials.Veeva

Menu

Differential Metabolic Effects of Fenofibrate and Fatty Acid

G

Gachon University Gil Medical Center

Status and phase

Completed
Phase 4

Conditions

Hypertriglyceridemia

Treatments

Drug: fenofibrate, fatty acid, placebo

Study type

Interventional

Funder types

Other

Identifiers

NCT01003847
GMC-200911

Details and patient eligibility

About

The investigators hypothesize that fenofibrate and fatty acid may have different metabolic effects in hypertriglyceridemic patients

Enrollment

150 patients

Sex

All

Ages

25 to 75 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • hypertriglyceridemia

Exclusion criteria

  • Overt liver disease Chronic renal failure Hypothyroidism Myopathy Uncontrolled diabetes Severe hypertension

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

150 participants in 3 patient groups

fenofibrate
Active Comparator group
Treatment:
Drug: fenofibrate, fatty acid, placebo
fatty acid
Active Comparator group
Description:
drug
Treatment:
Drug: fenofibrate, fatty acid, placebo
Placebo
Active Comparator group
Treatment:
Drug: fenofibrate, fatty acid, placebo

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems